Skip to content
Research Article Open access CC BY 4.0

Recent Advances in Cancer Immunotherapy: Clinical Implications and Future Directions

Anisha Nallasamy, Manju Rajput, Zahid Ahmad Wani, Maryam Khazir Dar, Aakanksha, Sheikh Hibban Fayaz, Subiksha S, Naveen H Simon

Journal of Cancer and Tumor International · pp. 7–13 · Published 4 May 2024

10.9734/jcti/2024/v14i2251

Abstract

Cancer immunotherapy has transformed cancer treatment by harnessing the immune system to recognize and eliminate cancer cells. Recent years have witnessed significant advancements in this field, including the development of immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, cancer vaccines, and adoptive cell therapy. These approaches have shown promising results in clinical trials, leading to improved outcomes for cancer patients. This paper provides an in-depth overview of recent advances in cancer immunotherapy, their clinical implications, challenges, and future directions.

Adoptive cell therapy cancer immunotherapy cancer vaccines CAR T-cell therapy Clinical implications Immune checkpoint inhibitors

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.